(Q74683304)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635914%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

review article

1 reference

title

Clinical strategies for serious infection: a North American perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635914%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

J P Quinn

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635914%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635914%20AND%20SRC:MED&resulttype=core&format=json

Diagnostic Microbiology and Infectious Disease

12 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635914%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635914%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635914%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

389-395

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635914%20AND%20SRC:MED&resulttype=core&format=json

Reevaluation of the factors involved in the efficacy of new beta-lactams against Enterobacter cloacae

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Meropenem: a microbiological overview

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Resistance to imipenem among selected gram-negative bacilli in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

In vitro activities of various beta-lactam antimicrobial agents against clinical isolates of Escherichia coli and Klebsiella spp. resistant to oxyimino cephalosporins

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Rapid emergence of resistance to cefepime during treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Multifocal outbreaks of metallo-beta-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum beta-lactams, including carbapenems.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

Incidence and characteristics of antibiotic use in aged nursing home patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2898%2900023-6

7 January 2021

10.1016/S0732-8893(98)00023-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9635914%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference